LY2033298
CAS No. 886047-13-8
LY2033298( —— )
Catalog No. M34325 CAS No. 886047-13-8
LY2033298, a positive allosteric modulator of muscarine M4 receptor, enhances the inhibitory effect of oximoline on light-induced phase shift in circadian activity in hamsters and can be used in neurosystem-related diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 204 | In Stock |
|
| 10MG | 347 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 797 | In Stock |
|
| 100MG | 1070 | In Stock |
|
| 200MG | 1442 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLY2033298
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2033298, a positive allosteric modulator of muscarine M4 receptor, enhances the inhibitory effect of oximoline on light-induced phase shift in circadian activity in hamsters and can be used in neurosystem-related diseases.
-
DescriptionLY 2033298 is a selective positive allosteric modulator of the muscarinic M4 receptor. LY 2033298 can be used in the study of psychiatric disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetAChR
-
RecptorAChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number886047-13-8
-
Formula Weight311.79
-
Molecular FormulaC13H14ClN3O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1nc2sc(C(=O)NC3CC3)c(N)c2c(C)c1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chan WY, et al. Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10978-83.?
molnova catalog
related products
-
(S)-UFR2709 hydrochl...
(S)-UFR2709 (hydrochloride) is a competitive nAChR antagonist with higher affinity for α4β2 nAChRs than for α7 nAChRs.
-
Tazomeline
Tazomeline is a muscarinic M1 receptor agonist with neuroprotective activity.
-
Metixene hydrochlori...
Metixene hydrochloride hydrate has potential anticholinergic activity and inhibits the binding of quinine ring benzoate (QNB) to muscarine receptors, with IC50 and Ki values of 55 nM and 15 nM, respectively.
Cart
sales@molnova.com